Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Lean NAFLD: an underrecognized and challenging disorder in medicine
Sheila Maier, Amanda Wieland, Melanie Cree‐Green, et al.
Reviews in Endocrine and Metabolic Disorders (2021) Vol. 22, Iss. 2, pp. 351-366
Open Access | Times Cited: 58

Showing 1-25 of 58 citing articles:

What Is New in Metabolic Dysfunction-Associated Steatotic Liver Disease in Lean Individuals: From Bench to Bedside
Pojsakorn Danpanichkul, Kanokphong Suparan, Donghee Kim, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 1, pp. 278-278
Open Access | Times Cited: 21
Recent advances in lean NAFLD
Ruohui Xu, Jiashu Pan, Wenjun Zhou, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 153, pp. 113331-113331
Open Access | Times Cited: 63
Metabolic-Dysfunction-Associated Fatty Liver Disease and Gut Microbiota: From Fatty Liver to Dysmetabolic Syndrome
Ludovico Abenavoli, Giuseppe Guido Maria Scarlata, Emidio Scarpellini, et al.
Medicina (2023) Vol. 59, Iss. 3, pp. 594-594
Open Access | Times Cited: 28
The fructose survival hypothesis for obesity
Richard J. Johnson, Miguel A. Lanaspa, Laura Gabriela Sánchez‐Lozada, et al.
Philosophical Transactions of the Royal Society B Biological Sciences (2023) Vol. 378, Iss. 1885
Open Access | Times Cited: 27
Exploring the role of genetic variations in NAFLD: implications for disease pathogenesis and precision medicine approaches
Seyedeh Kosar Mahmoudi, Shadi Tarzemani, Taha Aghajanzadeh, et al.
European journal of medical research (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 11
Current Therapeutic Landscape for Metabolic Dysfunction-Associated Steatohepatitis
Arun George Devasia, Adaikalavan Ramasamy, Chen Huei Leo
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 4, pp. 1778-1778
Open Access | Times Cited: 1
The relationship between serum uric acid level and non-alcoholic fatty liver disease in northern China: a retrospective cohort study
Qianjun He, Xinyue Liu, Guoyong Ding, et al.
BMC Public Health (2025) Vol. 25, Iss. 1
Open Access | Times Cited: 1
Long-term outcomes in lean and non-lean NAFLD patients: a systematic review and meta-analysis
Shaomin Huang, Yun Bao, Nawen Zhang, et al.
Endocrine (2023) Vol. 85, Iss. 1, pp. 134-141
Closed Access | Times Cited: 20
Non-pharmacological management options for MAFLD: a practical guide
José Tadeu Stefano, Sebastião Mauro Bezerra Duarte, Renato Gama Ribeiro Leite Altikes, et al.
Therapeutic Advances in Endocrinology and Metabolism (2023) Vol. 14
Open Access | Times Cited: 19
Lean or diabetic subtypes predict increased all-cause and disease-specific mortality in metabolic-associated fatty liver disease
Goh Eun Chung, Su Jong Yu, Jeong‐Ju Yoo, et al.
BMC Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 17
Rhinacanthin C Ameliorates Insulin Resistance and Lipid Accumulation in NAFLD Mice via the AMPK/SIRT1 and SREBP-1c/FAS/ACC Signaling Pathways
Zhiqiang Gong, Sha Han, Chenlin Li, et al.
Evidence-based Complementary and Alternative Medicine (2023) Vol. 2023, Iss. 1
Open Access | Times Cited: 17
Lean nonalcoholic fatty liver disease and sarcopenia
Milian Chen, Ying Cao, Guang Ji, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 16
Effects of Ganjianglingzhu Decoction on Lean Non-Alcoholic Fatty Liver Disease in Mice Based on Untargeted Metabolomics
Nan Tang, Lei Ji, Xinyu Shi, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 4, pp. 502-502
Open Access | Times Cited: 6
Adipocyte GPX4 protects against inflammation, hepatic insulin resistance and metabolic dysregulation
Julian Schwärzler, Lisa Mayr, Bernhard Radlinger, et al.
International Journal of Obesity (2022) Vol. 46, Iss. 5, pp. 951-959
Closed Access | Times Cited: 24
Nonalcoholic Fatty Liver Disease in Lean/Nonobese and Obese Individuals: A Comprehensive Review on Prevalence, Pathogenesis, Clinical Outcomes, and Treatment
Ankoor Patel, Dhiraj Peddu, Sahil Amin, et al.
Journal of Clinical and Translational Hepatology (2022) Vol. 000, Iss. 000, pp. 000-000
Open Access | Times Cited: 22
Inflammatory Bowel Disease Is an Independent Risk Factor for Metabolic Dysfunction–Associated Steatotic Liver Disease in Lean Individuals
Samuel J. Martínez‐Domínguez, Sandra G. García, Carla J. Gargallo-Puyuelo, et al.
Inflammatory Bowel Diseases (2023)
Open Access | Times Cited: 15
The metabolic profiles and body composition of non-obese metabolic associated fatty liver disease
Yujuan Zhang, Liu-lan Xiang, Fang Qi, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 5
Liver Steatosis is Prevalent in Lean People With HIV and Associated With Exposure to Antiretroviral Treatment—A Cross-sectional Study
Louise E. van Eekeren, Nadira Vadaq, W Vos, et al.
Open Forum Infectious Diseases (2024) Vol. 11, Iss. 6
Open Access | Times Cited: 5
Lean MASLD and Cardiovascular Disease: A Review
Nachum Lebovics, Gabriel Heering, William H. Frishman, et al.
Cardiology in Review (2025)
Closed Access
Non-alcoholic fatty liver disease (NAFLD) and mental illness: Mechanisms linking mood, metabolism and medicines
Anwesha Gangopadhyay, Radwa Ibrahim, Karli Theberge, et al.
Frontiers in Neuroscience (2022) Vol. 16
Open Access | Times Cited: 20
Diagnostic Performance of the Fibrosis-4 Index and Nonalcoholic Fatty Liver Disease Fibrosis Score in Lean Adults With Nonalcoholic Fatty Liver Disease
Huiyul Park, Eileen L. Yoon, Takanori Ito, et al.
JAMA Network Open (2023) Vol. 6, Iss. 8, pp. e2329568-e2329568
Open Access | Times Cited: 12
Sex differences in Murine MASH evoked by a Fructose-Palmitate-Cholesterol-Enriched Diet
Lakshmi Arivazhagan, Sofie Y. N. Delbare, Robin A. Wilson, et al.
JHEP Reports (2024) Vol. 7, Iss. 2, pp. 101222-101222
Open Access | Times Cited: 4
Nonalcoholic Fatty Liver Disease and Associated Risk Factors in a Community‐Based Sample of Mexican‐Origin Adults
David O. Garcia, Kristin E. Morrill, Melissa Lopez‐Pentecost, et al.
Hepatology Communications (2022) Vol. 6, Iss. 6, pp. 1322-1335
Open Access | Times Cited: 18
Correlation between the triglyceride-glucose index and the onset of atrial fibrillation in patients with non-alcoholic fatty liver disease
Yao Zhang, Leigang Wang, Jiaxin Qi, et al.
Diabetology & Metabolic Syndrome (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 9
Experimental models of fatty liver diseases: Status and appraisal
Hua Wang, Haiyuan Shen, Wonhyo Seo, et al.
Hepatology Communications (2023) Vol. 7, Iss. 7
Open Access | Times Cited: 9
Page 1 - Next Page

Scroll to top